Without reference to the regulatory and reimbursement structures that govern the translation of science and technology into practice and without a concerted effort by both providers and payers to integrate innovative new discoveries in science and technology into clinical care, patients will have to wait longer for medicine to truly become personalized, predictive, and preventive.
